2018-2023 United States Overactive Bladder Treatment Market Report (Status and Outlook)

Publisher Name :
Date: 09-Aug-2018
No. of pages: 86

In 2017, the Overactive Bladder Treatment market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In United States market, the top players include

- Astellas Pharma

- Allergan

- Pfizer

- Teva (Activas)

- Johnson & Johnson

Split by product types/category, covering

- Anticholinergics

- Mirabegron

- Botox

Split by applications/end use industries, covers

- Idiopathic Overactive Bladder

- Neurogenic Overactive Bladder

2018-2023 United States Overactive Bladder Treatment Market Report (Status and Outlook)

Table of Contents

2018-2023 United States Overactive Bladder Treatment Market Report (Status and Outlook)
1 Overactive Bladder Treatment Market Overview
1.1 Product Overview and Scope of Overactive Bladder Treatment
1.2 Overactive Bladder Treatment Market Segment by Types
1.2.1 United States Overactive Bladder Treatment Sales Present Situation and Outlook by Types (2013-2023)
1.2.2 United States Overactive Bladder Treatment Sales Market Share by Types in 2017
1.2.3 Anticholinergics
1.2.3.1 Major Players of Anticholinergics
1.2.4 Mirabegron
1.2.4.1 Major Players of Mirabegron
1.2.5 Botox
1.2.5.1 Major Players of Botox
1.3 United States Overactive Bladder Treatment Market Segment by Applications/End Use Industries
1.3.1 United States Overactive Bladder Treatment Sales Present Situation and Outlook by Applications/End Industrials (2013-2023)
1.3.2 United States Overactive Bladder Treatment Sales Market Share by Applications in 2017
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 United States Overactive Bladder Treatment Overview and Market Size (Value) (2013-2023)
1.4.1 United States Market Overactive Bladder Treatment Overview
1.4.2 United States Overactive Bladder Treatment Market Size (Value and Volume) Status and Forecast (2013-2023)
2 United States Overactive Bladder Treatment Sales, Revenue (Value) and Market Share by Players
2.1 United States Overactive Bladder Treatment Sales and Market Share by Players (2013-2018)
2.2 United States Overactive Bladder Treatment Revenue and Market Share by Players (2013-2018)
2.3 United States Overactive Bladder Treatment Average Price by Players in 2017
2.4 United States Overactive Bladder Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Overactive Bladder Treatment Market Competitive Situation and Trends
2.5.1 Overactive Bladder Treatment Market Concentration Rate
2.5.2 Overactive Bladder Treatment Market Share of Top 3 and Top 5 Players in 2017
2.5.3 Mergers & Acquisitions, Expansion
3 United States Overactive Bladder Treatment Sales, Revenue (Value) by Type and Application (2013-2018)
3.1 United States Overactive Bladder Treatment Sales, Revenue, Market Share and Price by Type (2013-2018)
3.1.1 United States Overactive Bladder Treatment Sales and Market Share by Type (2013-2018)
3.1.2 United States Overactive Bladder Treatment Revenue and Market Share by Type (2013-2018)
3.1.3 United States Overactive Bladder Treatment Price by Type (2013-2018)
3.2 United States Overactive Bladder Treatment Sales and Market Share by Application (2013-2018)
3.3 United States Market Overactive Bladder Treatment Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
4 United States Overactive Bladder Treatment Players Profiles and Sales Data
4.1 Astellas Pharma
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Overactive Bladder Treatment Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 Astellas Pharma Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.1.5 Astellas Pharma News
4.2 Allergan
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Overactive Bladder Treatment Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 Allergan Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.2.5 Allergan News
4.3 Pfizer
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Overactive Bladder Treatment Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Pfizer Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.3.5 Pfizer News
4.4 Teva (Activas)
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Overactive Bladder Treatment Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 Teva (Activas) Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.4.5 Teva (Activas) News
4.5 Johnson & Johnson
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Overactive Bladder Treatment Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 Johnson & Johnson Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.5.5 Johnson & Johnson News
5 United States Overactive Bladder Treatment Market Forecast (2018-2023)
5.1 United States Overactive Bladder Treatment Sales, Revenue and Price Forecast (2018-2023)
5.1.1 United States Overactive Bladder Treatment Sales and Growth Rate Forecast (2018-2023)
5.1.2 United States Overactive Bladder Treatment Revenue and Growth Rate Forecast (2018-2023)
5.1.3 United States Overactive Bladder Treatment Price Trend Forecast (2018-2023)
5.2 United States Overactive Bladder Treatment Sales Forecast by Type (2018-2023)
5.3 United States Overactive Bladder Treatment Sales Forecast by Application (2018-2023)
6 Production Cost Analysis of Overactive Bladder Treatment
6.1 Main Raw Materials of Overactive Bladder Treatment
6.1.1 List of Overactive Bladder Treatment Main Raw Materials
6.1.2 Overactive Bladder Treatment Main Raw Materials Price Analysis
6.1.3 Overactive Bladder Treatment Raw Materials Major Suppliers
6.1.4 Overactive Bladder Treatment Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Overactive Bladder Treatment
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Production Expenses
6.3 Overactive Bladder Treatment Manufacturing Process/Method
7 Value Chain, Purchasing Strategy and Downstream Buyers
7.1 Overactive Bladder Treatment Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Overactive Bladder Treatment Major Players in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Sales Channel
8.1.1 Direct Sales
8.1.2 Indirect Sales
8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Overactive Bladder Treatment Distributors/Traders List in United States
9 Market Influences Factors Analysis
9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Data Source
List of Tables and Figures

Figure Picture of Overactive Bladder Treatment
Table Product Specifications of Overactive Bladder Treatment
Figure United States Overactive Bladder Treatment Sales (volume) for Each Type (2013-2023)
Figure United States Overactive Bladder Treatment Sales Market Share by Types in 2017
Table Types of Overactive Bladder Treatment
Figure Product Picture of Anticholinergics
Table Major Players of Anticholinergics
Figure Product Picture of Mirabegron
Table Major Players of Mirabegron
Figure Product Picture of Botox
Table Major Players of Botox
Figure United States Overactive Bladder Treatment Sales Present Situation and Outlook by Applications (2013-2023)
Figure United States Overactive Bladder Treatment Sales Market Share by Applications in 2017
Table Applications of Overactive Bladder Treatment
Figure Idiopathic Overactive Bladder Examples
Figure Neurogenic Overactive Bladder Examples
Figure United States Overactive Bladder Treatment Revenue (Million USD) Status and Forecast (2013-2023)
Figure United States Overactive Bladder Treatment Sales (Volume) Status and Forecast (2013-2023)
Table United States Overactive Bladder Treatment Sales by Players (2013-2018)
Table United States Overactive Bladder Treatment Sales Market Share (%) by Players (2013-2018)
Figure United States Overactive Bladder Treatment Sales Market Share by Players in 2016
Figure United States Overactive Bladder Treatment Sales Market Share by Players in 2017
Table United States Overactive Bladder Treatment Revenue (Million USD) by Players (2013-2018)
Table United States Overactive Bladder Treatment Revenue Market Share (%) by Players (2013-2018)
Figure United States Overactive Bladder Treatment Revenue Market Share by Players in 2016
Figure United States Overactive Bladder Treatment Revenue Market Share by Players in 2017
Figure United States Overactive Bladder Treatment Average Price by Players in 2017
Table United States Overactive Bladder Treatment Manufacturing Base Distribution and Sales Area by Players
Table Players Overactive Bladder Treatment Product Types
Figure Overactive Bladder Treatment Market Share of Top 3 Players in 2017
Figure Overactive Bladder Treatment Market Share of Top 5 Players in 2017
Table United States Overactive Bladder Treatment Sales by Type (2013-2018)
Table United States Overactive Bladder Treatment Sales Market Share by Type (2013-2018)
Figure United States Overactive Bladder Treatment Sales Market Share by Type in 2013
Figure United States Overactive Bladder Treatment Sales Market Share by Type in 2017
Table United States Overactive Bladder Treatment Revenue (Million USD) by Type (2013-2018)
Table United States Overactive Bladder Treatment Revenue Market Share by Type (2013-2018)
Figure United States Overactive Bladder Treatment Revenue Market Share by Type in 2013
Figure United States Overactive Bladder Treatment Revenue Market Share by Type in 2017
Table United States Overactive Bladder Treatment Price by Type (2013-2018)
Table United States Overactive Bladder Treatment Sales by Application (2013-2018)
Table United States Overactive Bladder Treatment Sales Market Share by Application (2013-2018)
Figure United States Overactive Bladder Treatment Sales Market Share by Application (2013-2018)
Figure United States Overactive Bladder Treatment Sales Market Share by Application in 2017
Table United States Market Overactive Bladder Treatment Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharma Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Pharma Overactive Bladder Treatment Market Share (2012-2017)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Overactive Bladder Treatment Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Overactive Bladder Treatment Market Share (2012-2017)
Table Teva (Activas) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva (Activas) Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva (Activas) Overactive Bladder Treatment Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Overactive Bladder Treatment Market Share (2012-2017)
Figure United States Overactive Bladder Treatment Sales and Growth Rate Forecast (2018-2023)
Figure United States Overactive Bladder Treatment Revenue and Growth Rate Forecast (2018-2023)
Figure United States Overactive Bladder Treatment Price Trend Forecast (2018-2023)
Table United States Overactive Bladder Treatment Sales Forecast by Type (2018-2023)
Figure United States Overactive Bladder Treatment Sales Market Share Forecast by Type (2018-2023)
Figure United States Overactive Bladder Treatment Sales Market Share Forecast by Type in 2023
Table United States Overactive Bladder Treatment Sales Forecast by Application (2018-2023)
Figure United States Overactive Bladder Treatment Sales Market Share Forecast by Application (2018-2023)
Figure United States Overactive Bladder Treatment Sales Market Share Forecast by Application in 2023
Table Production Base and Market Concentration Rate of Raw Material
Figure Overactive Bladder Treatment Main Raw Materials Price Trend
Table Overactive Bladder Treatment Raw Materials Major Suppliers List
Figure Production Cost Structure of Overactive Bladder Treatment
Figure Overactive Bladder Treatment Manufacturing Process/Method
Figure Overactive Bladder Treatment Value Chain Analysis
Table Raw Materials Sources of Overactive Bladder Treatment Major Players in 2017
Table Major Buyers of Overactive Bladder Treatment
Table Overactive Bladder Treatment Distributors/Traders List in United States
  • Global Genitourinary Drugs Market Insights, Forecast to 2025
    Published: 15-May-2019        Price: US 3900 Onwards        Pages: 113
    A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of pipeline drugs are expected to widen the scope for growth in the future. The global Genitourinary Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end......
  • Global Overactive Bladder Treatment Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2024
    Published: 14-May-2019        Price: US 2600 Onwards        Pages: 139
    In this report, we analyze the Overactive Bladder Treatment industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We a......
  • Global Genitourinary Drugs Market Analysis 2013-2018 and Forecast 2019-2024
    Published: 09-May-2019        Price: US 2980 Onwards        Pages: 86
    Summary The global Genitourinary Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Genitourinary Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this repor......
  • Global Genitourinary Drugs Industry Market Research Report
    Published: 02-May-2019        Price: US 2960 Onwards        Pages: 121
    The Genitourinary Drugs market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Genitourinary Drugs industrial chain, this report mainly elaborates the definition, types, applications and major players of Genitourinary Drugs market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, indust......
  • Drugs for Urinary Tract Infections Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 23-Apr-2019        Price: US 3000 Onwards        Pages: 147
    Drugs for Urinary Tract Infections Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Drugs for Urinary Tract Infections industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drugs for Urinary Tract Infections manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth i......
  • Overactive Bladder Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 20-Apr-2019        Price: US 3000 Onwards        Pages: 150
    Overactive Bladder Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Overactive Bladder industry with a focus on the Chinese market. The report provides key statistics on the market status of the Overactive Bladder manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Overactiv......
  • Global Overactive Bladder Treatment Market Analysis 2013-2018 and Forecast 2019-2024
    Published: 27-Mar-2019        Price: US 2980 Onwards        Pages: 90
    Summary Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). The global Overactive Bladder Treatment market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and......
  • Global Overactive Bladder Treatment Market Data Survey Report 2013-2025
    Published: 19-Mar-2019        Price: US 1500 Onwards        Pages: 55
    Summary Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). The global Overactive Bladder Treatment market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production dat......
  • Global Genitourinary Drugs Market Research Report 2019
    Published: 21-Feb-2019        Price: US 2900 Onwards        Pages: 99
    A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of pipeline drugs are expected to widen the scope for growth in the future. The global Genitourinary Drugs market is valued at xx million US$ in 2018 is expected to reach xx million ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs